Try our corporate solution for free!
(212) 419-8294
vianny.gutierrez-cruz@statista.com

U.S. prescription market: market share of pharmacy benefit managers 2021

Market share of the top pharmacy benefit managers in the U.S. prescription market in 2021

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Single Account

$39 $59 per month *
in the first 12 months
33% off until Jun 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2022

Region

United States

Survey time period

2021

Supplementary notes

Market share based on total prescription claims. Missing percentage points to 100 percent are probably due to rounding.
* Includes Cigna claims which fully transitioned to Express Scripts by the end of 2020, and a portion of Prime Therapeutics network.
** Excludes estimates of 2021 claims for which Express Scripts handles pharmacy network contracting.
*** Figure includes some cash pay prescriptions that use a discount card processed by one of the 6 PBMs shown on the chart.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "U.S. pharmaceutical industry"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.